BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Fuji
Deloitte
Moodys
Express Scripts
US Department of Justice
Merck
Accenture
McKesson
Boehringer Ingelheim

Generated: January 23, 2018

DrugPatentWatch Database Preview

PEDIAMYCIN Drug Profile

« Back to Dashboard

Which patents cover Pediamycin, and when can generic versions of Pediamycin launch?

Pediamycin is a drug marketed by Ross Labs and Arbor Pharms Llc and is included in three NDAs.

The generic ingredient in PEDIAMYCIN is erythromycin ethylsuccinate. There are one hundred and one drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.

US Patents and Regulatory Information for PEDIAMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ross Labs PEDIAMYCIN erythromycin ethylsuccinate GRANULE;ORAL 062305-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ross Labs PEDIAMYCIN erythromycin ethylsuccinate TABLET, CHEWABLE;ORAL 062306-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ross Labs PEDIAMYCIN erythromycin ethylsuccinate SUSPENSION/DROPS;ORAL 062305-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Arbor Pharms Llc PEDIAMYCIN erythromycin ethylsuccinate SUSPENSION;ORAL 062304-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Arbor Pharms Llc PEDIAMYCIN 400 erythromycin ethylsuccinate SUSPENSION;ORAL 062304-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Mallinckrodt
McKinsey
Daiichi Sankyo
Chubb
Federal Trade Commission
Fuji
Deloitte
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot